FIELD: otorhinolaryngology.
SUBSTANCE: invention relates to otorhinolaryngology. The method includes infusion intravenous therapy: dexamethasone in a decreasing pattern, while dexamethasone is administered 4 mg/ml per 100 ml of saline, and on the first and second days - 24 mg, on the third and fourth days - 16 mg, on the fifth day - 8 mg, the sixth day - 4 mg, the seventh day - the drug is not administered, the eighth day - 4 mg. At the same time, dexamethasone is combined with a triazino-indole derivative 10 mg/ml - 4 ml per 100 ml of physiological solution daily for 7 days, while the resulting solution is administered intravenously, 60-70 drops per minute, once a day.
EFFECT: method allows to improve the patient's subjective state: eliminate tinnitus and increase the perception of whispered speech, as well as hearing thresholds according to tone threshold audiometry, otoacoustic emission indicators.
1 cl, 8 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF MODELING SENSONEURAL HEARING LOSS | 2016 |
|
RU2627155C1 |
AGENT AND METHOD FOR TREATING SENSORINEURAL HEARING LOSS | 2018 |
|
RU2698451C1 |
SCREENING METHOD FOR DETECTING HEARING DISORDERS IN PRESCHOOL CHILDREN | 2020 |
|
RU2759485C1 |
METHOD FOR THE PREVENTION OF AUDITORY FUNCTION DISORDERS IN HUMANS WHEN EXPOSED TO NOISE | 2021 |
|
RU2779973C1 |
METHOD OF TREATING ACUTE AND SUDDEN SENSORINEURAL HEARING LOSS AND DEAFNESS | 2014 |
|
RU2563829C1 |
AGENT FOR TREATMENT OF PATIENTS WITH ACUTE AND SUDDEN SENSONEURAL DIMINISHED HEARING AND DEAFNESS | 1997 |
|
RU2119335C1 |
METHOD OF EARLY EXTENDED AUDIOLOGIC DIAGNOSTICS OF AUDITORY DISORDERS, CAUSED BY DISSEMINATED SCLEROSIS | 2007 |
|
RU2374983C2 |
METHOD FOR SURGICAL TREATMENT OF CHRONIC SECONDARY SENSONEURAL DEAFNESS | 2016 |
|
RU2651110C1 |
METHOD FOR TREATING NEUROSENSORY HYPOACUSIA | 2001 |
|
RU2188642C1 |
METHOD FOR EVALUATING RESTORED AUDITORY FUNCTION IN ACUTE PERIOD OF SENSONEURAL IMPAIRED HEARING | 2002 |
|
RU2224256C2 |
Authors
Dates
2022-11-10—Published
2022-03-11—Filed